Search clinical trials for: Rituximab - Bendamustine
Total 3297 results
-
Medical University of ViennaNot yet recruiting
-
National Cancer Institute (NCI)WithdrawnExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone LymphomaUnited States
-
Georg Hess, MDWyeth is now a wholly owned subsidiary of Pfizer; Mundipharma Pte Ltd.CompletedFollicular Lymphoma | Mantle Cell LymphomaGermany
-
Samsung Medical CenterUnknownMantle Cell LymphomaKorea, Republic of
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedChronic Lymphocytic LeukemiaItaly
-
The Lymphoma Academic Research OrganisationTerminated
-
National Research Center for Hematology, RussiaUnknown
-
Gruppo Italiano Studio LinfomiCompletedBendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative DisordersRelapsed or Refractory Chronic Lymphoproliferative DisordersItaly
-
Fondazione Italiana Linfomi ONLUSUnknownDiffuse Large B-cell LymphomaItaly
-
International Extranodal Lymphoma Study Group (IELSG)CompletedMarginal Zone B-cell LymphomaItaly, France
-
Seoul National University HospitalChonbuk National University Hospital; Seoul National University Bundang Hospital and other collaboratorsCompletedMarginal Zone B-cell LymphomaKorea, Republic of
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
Southwest Oncology GroupNational Cancer Institute (NCI)Withdrawn
-
CephalonCompletedNon-Hodgkin's LymphomaUnited States, Australia, Canada
-
Grupo Oncológico para el Tratamiento y el Estudio...UnknownFollicular Non-Hodgking´s Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line.Spain
-
CelgeneThe Lymphoma Academic Research OrganisationActive, not recruitingFollicular LymphomaUnited States, Japan
-
PharmatechCephalonCompletedDiffuse Large B-Cell LymphomaUnited States
-
University of GöttingenRoche Pharma AG; Mundipharma Research GmbH & Co KGCompleted
-
Astellas Pharma Europe B.V.CompletedChronic Lymphocytic LeukemiaRussian Federation
-
Astellas Pharma Europe B.V.CompletedLymphoma, Non-HodgkinRussian Federation
-
Asan Medical CenterCheolwon SuhRecruitingDiffuse Large B Cell LymphomaKorea, Republic of
-
The Lymphoma Academic Research OrganisationCelgene CorporationActive, not recruitingFollicular LymphomaSpain, Canada, France, Australia, Italy, Belgium, Germany, Portugal
-
Helse FonnaCompletedAutoimmune Hemolytic Anemia | Cold Agglutinin DiseaseFinland, Denmark, Norway
-
Genentech, Inc.AbbVie (prior sponsor, Abbott)WithdrawnDiffuse Large B-Cell LymphomaUnited States
-
Czech CLL Study GroupCompleted
-
Fondazione Italiana Linfomi ONLUSCompletedWaldenstrom's MacroglobulinemiaItaly
-
University Hospital TuebingenArbeitsgemeinschaft fur Internistische Onkologie; German Sarcoma GroupCompleted
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicFinland, France, Spain, Portugal, Turkey, United Kingdom, Sweden, Tunisia
-
University of RochesterMillennium Pharmaceuticals, Inc.; CephalonCompletedNon-Hodgkin's LymphomaUnited States
-
Ruijin HospitalRecruiting
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Mantle Cell LymphomaUnited States
-
Incyte CorporationWithdrawn
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Czech Lymphoma Study GroupNot yet recruitingLymphoma, Mantle-CellCzechia
-
Charite University, Berlin, Germanyribosepharm GmbHUnknownRecurrent Small Cell Lung CancerGermany
-
Institute of Hematology & Blood Diseases HospitalRecruiting
-
MorphoSys AGICON Clinical ResearchActive, not recruitingDiffuse Large B-cell LymphomaUnited States, Hungary, Italy, Poland, Spain, Czechia, Germany, Australia, Austria, Canada, Croatia, Finland, France, Israel, Korea, Republic of, New Zealand, Portugal, Romania, Serbia, Singapore, Taiwan, Turkey, United Kingdom
-
Yale UniversityWithdrawnHematopoietic/Lymphoid Cancer | Infectious Mononucleosis | PTLD | Lymphoid Tumor | Plasmacytic Hyperplasia PTLD | Florid Follicular Hyperplasia PTLD | Polymorphic PTLD | Monomorphic PTLD | Classical Hodgkin Lymphoma Type PTLDUnited States
-
Kami Maddocks, MDPharmacyclics LLC.Active, not recruitingExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent... and other conditionsUnited States
-
University of Wisconsin, MadisonGenentech, Inc.; Celgene CorporationWithdrawnChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)
-
University of GiessenCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaGermany
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Completed
-
UNC Lineberger Comprehensive Cancer CenterCephalonCompletedLymphoma | Diffuse Large B-Cell Lymphoma | Lymphoma, Diffuse Large-Cell | Diffuse Large-Cell LymphomaUnited States
-
CephalonCompletedMantle Cell LymphomaUnited States, Canada
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.Completed
-
BeiGeneActive, not recruitingMantle Cell Lymphoma; Non-Hodgkin LymphomaJapan
-
University of California, DavisNovartisCompletedMultiple Myeloma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Adult Hodgkin Lymphoma | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Untreated Adult Acute Myeloid... and other conditionsUnited States
-
Fondazione Italiana Linfomi ONLUSCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Celgene CorporationCompletedRefractory/Relapsed Indolent Non-Hodgkin LymphomaUnited States